QURE
uniQure N.V.
QURE lost money over the past year, so it has no meaningful PE right now.
QURE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Strong |
QURE's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
QURE PE Valuation
QURE has no meaningful PE right now: it lost money over the past year.
QURE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect QURE's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
QURE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.52 | +$0.86 |
| Q2 2026 | -$4.02 | -$0.11 |
| Q1 2026 | -$3.49 | +$0.89 |
| Q4 2025 | -$3.46 | +$1.46 |
| Q3 2025 | -$4.38 | +$0.57 |
| Q2 2025 | -$3.91 | +$2.01 |
| Q1 2025 | -$4.38 | +$1.82 |
| Q4 2024 | -$4.92 | +$1.55 |
QURE is still losing money, but less than at its worst: $3.52 per share over the past year, against $6.47 at its worst in late 2023.
QURE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.2M | +40% |
| Q2 2026 | $5.8M | +11% |
| Q1 2026 | $3.6M | +127% |
| Q4 2025 | $5.6M | +6.6% |
| Q3 2025 | $3.7M | +62% |
| Q2 2025 | $5.3M | -53% |
| Q1 2025 | $1.6M | -82% |
| Q4 2024 | $5.2M | -22% |
QURE's revenue is recovering but still below its 2021 peak: $5M last quarter, up 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1020% | +359 points |
| Q2 2026 | -894% | -60 points |
| Q1 2026 | -1284% | +1226 points |
| Q4 2025 | -918% | -40 points |
| Q3 2025 | -1379% | +380 points |
| Q2 2025 | -834% | -438 points |
| Q1 2025 | -2510% | -1871 points |
| Q4 2024 | -878% | +45 points |
QURE's operating margin was −1020% last quarter, up 359 points from the same quarter a year ago.
QURE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.8M | -$31.5M |
| Q2 2026 | -$29M | +$11.1M |
| Q1 2026 | -$38.4M | +$5.8M |
| Q4 2025 | -$77.7M | -$24.8M |
| Q3 2025 | -$16.3M | +$20.6M |
| Q2 2025 | -$40.2M | -$6.8M |
| Q1 2025 | -$44.2M | +$18.7M |
| Q4 2024 | -$52.9M | -$1.3M |
QURE has burned cash in almost every quarter: −$193M over the past year, against −$154M the year before.
QURE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | -1.4x | Net Cash |
| Q4 2021 | -1.4x | Net Cash |
QURE has more cash than debt.
QURE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 10.8 | Oversold |
QURE's weekly RSI is 41 (neutral) and its Stochastic is 11 (oversold).
QURE PE vs Healthcare Sector
| Metric | QURE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
QURE has no meaningful PE right now: it lost money over the past year.
QURE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.0 | 1.3% below |
| 20 week MA | $36.6 | 33% below |
| 50 week MA | $28.6 | 14% below |
| 100 week MA | $24.8 | 0.6% below |
| 200 week MA | $17.3 | 43% above |
QURE has fallen below most of its moving averages, though it's still 43% above its 200-week average.
QURE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.5 | $38.1 | -47% |
| 2021 | $38.1 | $22.3 | -42% |
| 2022 | $22.3 | $23.3 | +4.7% |
| 2023 | $23.3 | $6.77 | -71% |
| 2024 | $6.77 | $17.5 | +158% |
| 2025 | $17.5 | $24.8 | +42% |
| 2026 YTD | $24.8 | $24.6 | -0.7% |
QURE's yearly returns have swung widely, from +158% in 2024 to −71% in 2023. It's down 0.7% so far in 2026.